Zidovudine |
|
|
|
|
|
Increase |
Positive |
|
307 |
Acyclovir |
|
|
|
|
|
Increase |
Positive |
|
307 |
Ganciclovir |
|
|
|
|
|
Increase |
Positive |
|
307 |
Zalcitabine |
|
|
|
|
|
Increase |
Positive |
|
307 |
amphotericin B |
2.5mg/ml |
|
Aspergillus fumigatus |
|
oxidant-sensing fluorescent probe 2′,7′-dichlorofluorescin diacetate t |
induce |
Positive |
|
304 |
Terbinafine |
4mg/ml |
|
Aspergillus fumigatus |
|
oxidant-sensing fluorescent probe 2′,7′-dichlorofluorescin diacetate t |
induce |
Positive |
|
304 |
itraconazole |
4mg/ml |
|
Aspergillus fumigatus |
|
oxidant-sensing fluorescent probe 2′,7′-dichlorofluorescin diacetate t |
induce |
Positive |
|
304 |
tacrolimus |
50 µg/ml |
12hr |
|
INS-1 cells |
MitoSOX Red staining to detect mitochondrial superoxide anion (O2−) levels by flow cytometric analysis and e time-lapse images of cells treated for 12 h with MitoSOX Red. |
induce |
Positive |
|
322 |
P110 |
1 µM |
2hr |
|
SH-SY5Y cells were treated with P110 (1 µM) followed by incubation of MPP+ (2 mM) for 2 hours. |
Mitochondrial superoxide production was determined using the mitochondrial superoxide indicator MitoSOX Red. Total ROS production was determined in SH-SY5Y cells using CM2-HDCFA. |
reduce |
Positive |
|
310 |
neomycin |
50 μM |
|
zebrafish |
zebrafish lateral line hair |
use ROS indicator dye cellROX green ( it labels a number of intracellular compartments, including cytoplasm, nucleus, and mitochondria) |
increase |
Positive |
|
315 |
Diflunisal |
558 |
|
rat |
hepatocytes |
use CM-H2DCFDA to monitor reactive oxygen species |
|
Positive |
AC50 (μM) |
40 |
Sulindac sulfide |
109 |
|
rat |
hepatocytes |
use CM-H2DCFDA to monitor reactive oxygen species |
|
Positive |
AC50 (μM) |
40 |
Nimesulide |
574 |
|
rat |
hepatocytes |
use CM-H2DCFDA to monitor reactive oxygen species |
|
Positive |
AC50 (μM) |
40 |
Staurosporine |
2 µM |
24hr |
|
U2OS |
mt-roGFP and mitoSOX |
increase |
Positive |
|
313 |
camptothecin |
30 µM |
24hr |
|
U2OS |
mt-roGFP and mitoSOX |
increase |
Positive |
|
313 |
Menadione |
20 µM |
24hr |
|
U2OS |
mt-roGFP and mitoSOX |
increase |
Positive |
|
313 |
Cisplatin |
150 µM |
24hr |
|
U2OS |
U2OS cells stably expressing mt-roGFP and HyPer-red targeted at mitochondria |
increase |
Positive |
|
313 |
camptothecin |
30 µM |
24hr |
|
U2OS |
U2OS cells stably expressing mt-roGFP and HyPer-red targeted at mitochondria |
increase |
Positive |
|
313 |
Ciprofloxacin |
|
|
|
|
|
Increase |
Positive |
|
307 |
Mitoquinone |
|
|
|
U2OS |
mt-roGFP ratio change (Quantitative representation of the percentage of cell death in cells pre-treated with MitoQ followed by drug treatment or drug alone as indicated for 24 h) |
reduce |
Positive |
|
313 |
Cisplatin |
|
|
|
|
|
Increase |
Positive |
|
307 |
Cyclophosphamide |
|
|
|
|
|
Increase |
Positive |
|
307 |
Gentamicin |
5mM |
10min |
rat |
isolated rat liver (and kidney) mitochondria |
Mitochondrial ROS production can be measured using Amplex Red, a dye that fluoresces dependent on hydrogen peroxide (H2O2) levels. |
reduce |
Positive |
|
316 |
glyceraldehyde 3-phosphate |
2.5mM |
|
|
|
|
decrease |
Positive |
|
162 |
dihydroxyacetone phosphate |
|
|
|
|
|
decrease |
Positive |
|
162 |
MG-132 |
20 μM |
24 hr |
rat |
PC12 cells |
Measurement of intracellular ROS formation with DCFH2-DA |
increase |
Positive |
|
289 |
Amitriptyline |
|
|
|
|
|
|
Positive |
|
197 |
3-morpholinosydnonimine |
150 μM |
24 hr |
rat |
PC12 cells |
Measurement of intracellular ROS formation with DCFH2-DA |
decrease |
Positive |
|
289 |
Desipramine |
|
|
|
|
|
|
Positive |
|
197 |
Valproic Acid |
|
|
|
|
|
increase |
Positive |
|
197 |
Doxorubicin |
|
|
|
|
|
increase |
Positive |
|
197 |
Efavirenz |
|
|
|
|
|
increase |
Positive |
|
197 |
Propofol |
|
|
|
|
|
increase |
Positive |
|
197 |
Ketamine |
|
|
|
|
|
increase |
Positive |
|
197 |
Manganese |
15 mg/l in drinking water |
|
Swiss Albino mice |
|
|
increase |
Positive |
|
242 |
Paraquat |
10 mg/kg/week intraperitoneal (i.p.) |
4 weeks |
C57BL/6 mice |
|
|
|
Positive |
|
242 |
Paraquat |
250 μM |
5min |
Sprague Dawley rat |
brain cultures |
|
|
Positive |
|
242 |
Rotenone |
0.1–0.5 nmol/mg protein |
|
Wistar rat |
brain isolated mitochondria |
|
increase |
Positive |
|
242 |
Cisplatin |
84.96 ± 3, 158.9 ± 8.2, 372.7 ± 17.5 and 499.5 ± 15.1 μM |
24 hr |
|
Ishikawa, MDA-MB-231, PC-3 and Caco-2 |
Intracellular ROS (a) and mitochondrial superoxide were measured by fluorescence intensity of H2DCFDA and MitoSOX respectively. |
increase |
Positive |
IC50 |
299 |
Dequalinium Chloride |
14.24 ± 0.59, 57.85 ± 3.59, 93.31 ± 3.21 and 179.2 ± 5.2 μM |
24 hr |
|
Ishikawa, MDA-MB-231, PC-3 and Caco-2 |
Intracellular ROS (a) and mitochondrial superoxide were measured by fluorescence intensity of H2DCFDA and MitoSOX respectively. |
increase |
Positive |
IC50 |
299 |
Amiodarone |
10 µM |
1 hour |
Human |
HepG2 |
High-content screening assay |
Increase |
Positive |
MEC |
306 |
Chlorpromazine |
50 µM |
1 hour |
Human |
HepG2 |
High-content screening assay |
Increase |
Positive |
MEC |
306 |
Aluminium |
10 mg/kg/day intragastric for 12 weeks |
|
Wistar rats |
|
|
|
Positive |
|
242 |
Cyclosporin A |
5 µM |
1 hour |
Human |
HepG2 |
High-content screening assay |
Increase |
Positive |
MEC |
306 |
imipramine |
50 µM |
1 hour |
Human |
HepG2 |
High-content screening assay |
Increase |
Positive |
MEC |
306 |
Maprotiline |
5 µM |
1 hour |
Human |
HepG2 |
High-content screening assay |
Increase |
Positive |
MEC |
306 |
Rotenone |
100 µM |
1 hour |
Human |
HepG2 |
High-content screening assay |
Increase |
Positive |
MEC |
306 |
Tamoxifen |
5 µM |
1 hour |
Human |
HepG2 |
High-content screening assay |
Increase |
Positive |
MEC |
306 |
Troglitazone |
10 µM |
1 hour |
Human |
HepG2 |
High-content screening assay |
Increase |
Positive |
MEC |
306 |
atorvastatin |
100 µM |
1 hour |
Human |
HepG2 |
High-content screening assay |
Increase |
Positive |
MEC |
306 |
Cerivastatin |
5 µM |
1 hour |
Human |
HepG2 |
High-content screening assay |
Increase |
Positive |
MEC |
306 |
fluvastatin |
50 µM |
1 hour |
Human |
HepG2 |
High-content screening assay |
Increase |
Positive |
MEC |
306 |
lovastatin |
10 µM |
1 hour |
Human |
HepG2 |
High-content screening assay |
Increase |
Positive |
MEC |
306 |
pravastatin |
50 µM |
1 hour |
Human |
HepG2 |
High-content screening assay |
Increase |
Positive |
MEC |
306 |
Simvastatin |
5 µM |
1 hour |
Human |
HepG2 |
High-content screening assay |
Increase |
Positive |
MEC |
306 |
Methylmercury |
15 mg/l in drinking water |
|
Swiss albino mice |
|
|
|
Positive |
|
242 |